vs
康美（CNMD）与IRIDEX CORP（IRIX）财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是IRIDEX CORP的25.3倍（$373.2M vs $14.7M），康美同比增速更快（7.9% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs 9.3%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
CNMD vs IRIX — 直观对比
营收规模更大
CNMD
是对方的25.3倍
$14.7M
营收增速更快
CNMD
高出77.6%
-69.7%
两年增速更快
IRIX
近两年复合增速
9.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $14.7M |
| 净利润 | — | — |
| 毛利率 | 58.5% | 37.2% |
| 营业利润率 | 9.8% | — |
| 净利率 | — | — |
| 营收同比 | 7.9% | -69.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.54 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDIRIX
| Q4 25 | $373.2M | $14.7M | ||
| Q3 25 | $337.9M | $12.5M | ||
| Q2 25 | $342.3M | $13.6M | ||
| Q1 25 | $321.3M | $11.9M | ||
| Q4 24 | $345.9M | $12.7M | ||
| Q3 24 | $316.7M | $11.6M | ||
| Q2 24 | $332.1M | $12.6M | ||
| Q1 24 | $312.3M | $11.8M |
净利润CNMDIRIX
| Q4 25 | — | — | ||
| Q3 25 | $2.9M | $-1.6M | ||
| Q2 25 | $21.4M | $-994.0K | ||
| Q1 25 | $6.0M | $-1.7M | ||
| Q4 24 | — | $-834.0K | ||
| Q3 24 | $49.0M | $-1.9M | ||
| Q2 24 | $30.0M | $-2.7M | ||
| Q1 24 | $19.7M | $-3.5M |
毛利率CNMDIRIX
| Q4 25 | 58.5% | 37.2% | ||
| Q3 25 | 49.2% | 32.1% | ||
| Q2 25 | 55.0% | 34.5% | ||
| Q1 25 | 55.3% | 42.5% | ||
| Q4 24 | 57.3% | 44.0% | ||
| Q3 24 | 56.5% | 37.3% | ||
| Q2 24 | 55.3% | 40.7% | ||
| Q1 24 | 55.1% | 37.9% |
营业利润率CNMDIRIX
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | -11.3% | ||
| Q2 25 | 11.1% | -6.9% | ||
| Q1 25 | 5.0% | -1.7% | ||
| Q4 24 | 15.2% | -3.9% | ||
| Q3 24 | 20.7% | -16.1% | ||
| Q2 24 | 14.2% | -20.9% | ||
| Q1 24 | 11.2% | -28.0% |
净利率CNMDIRIX
| Q4 25 | — | — | ||
| Q3 25 | 0.8% | -12.6% | ||
| Q2 25 | 6.3% | -7.3% | ||
| Q1 25 | 1.9% | -14.2% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | 15.5% | -16.7% | ||
| Q2 24 | 9.0% | -21.2% | ||
| Q1 24 | 6.3% | -29.5% |
每股收益（稀释后）CNMDIRIX
| Q4 25 | $0.54 | — | ||
| Q3 25 | $0.09 | $-0.09 | ||
| Q2 25 | $0.69 | $-0.06 | ||
| Q1 25 | $0.19 | $-0.10 | ||
| Q4 24 | $1.09 | $-0.05 | ||
| Q3 24 | $1.57 | $-0.12 | ||
| Q2 24 | $0.96 | $-0.16 | ||
| Q1 24 | $0.63 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $6.0M |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | — |
| 总资产 | $2.3B | $29.2M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
现金及短期投资CNMDIRIX
| Q4 25 | — | $6.0M | ||
| Q3 25 | — | $5.6M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | — | $5.4M |
总债务CNMDIRIX
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | $1.0M | ||
| Q3 24 | $940.1M | $1.4M | ||
| Q2 24 | $965.2M | — | ||
| Q1 24 | $990.1M | — |
股东权益CNMDIRIX
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.0B | $4.7M | ||
| Q2 25 | $1.0B | $6.1M | ||
| Q1 25 | $977.6M | $852.0K | ||
| Q4 24 | $962.7M | $2.1M | ||
| Q3 24 | $932.9M | $2.6M | ||
| Q2 24 | $881.8M | $4.2M | ||
| Q1 24 | $854.7M | $6.5M |
总资产CNMDIRIX
| Q4 25 | $2.3B | $29.2M | ||
| Q3 25 | $2.3B | $28.4M | ||
| Q2 25 | $2.3B | $31.6M | ||
| Q1 25 | $2.3B | $34.2M | ||
| Q4 24 | $2.3B | $29.1M | ||
| Q3 24 | $2.3B | $30.2M | ||
| Q2 24 | $2.3B | $31.2M | ||
| Q1 24 | $2.3B | $34.1M |
负债/权益比CNMDIRIX
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | 0.48× | ||
| Q3 24 | 1.01× | 0.53× | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | — |
| 自由现金流经营现金流 - 资本支出 | $41.2M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $150.9M | — |
8季度趋势，按日历期对齐
经营现金流CNMDIRIX
| Q4 25 | $46.3M | — | ||
| Q3 25 | $53.7M | $-1.2M | ||
| Q2 25 | $29.1M | $-397.0K | ||
| Q1 25 | $41.5M | $-1.1M | ||
| Q4 24 | $43.3M | $-1.2M | ||
| Q3 24 | $51.2M | $-3.1M | ||
| Q2 24 | $43.3M | $-1.3M | ||
| Q1 24 | $29.1M | $-1.6M |
自由现金流CNMDIRIX
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | $-1.2M | ||
| Q2 25 | $23.4M | $-410.0K | ||
| Q1 25 | $37.8M | $-1.2M | ||
| Q4 24 | $39.3M | $-1.2M | ||
| Q3 24 | $47.8M | $-3.1M | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | $27.1M | $-1.7M |
自由现金流率CNMDIRIX
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | -9.4% | ||
| Q2 25 | 6.8% | -3.0% | ||
| Q1 25 | 11.8% | -9.8% | ||
| Q4 24 | 11.4% | -9.8% | ||
| Q3 24 | 15.1% | -26.5% | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.7% | -14.0% |
资本支出强度CNMDIRIX
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | 0.1% | ||
| Q2 25 | 1.7% | 0.1% | ||
| Q1 25 | 1.2% | 0.1% | ||
| Q4 24 | 1.2% | 0.1% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 0.7% | 0.0% |
现金转化率CNMDIRIX
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
IRIX
暂无分部数据
